English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduMIDDLETON, Wis., January 19, 2021 – Approximately 1,000 researchers and clinicians are expected to attend the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum Feb. 25-27, 2021.
ACTRIMS Forum 2021 will provide an excellent opportunity to interact with scientists and clinicians at the cutting edge of MS research. Themed “The Spectrum of Multiple Sclerosis,” the meeting will examine MS through the lifespan, environmental impacts, and disease severity, along with a session from the Latin American Committee for Treatment and Research in Multiple Sclerosis (LACTRIMS) focused on MS in the Hispanic and Latino populations. This CME-accredited meeting stands apart from many traditional medical meetings by offering a single track of scientific and clinical presentations in an interactive environment with approximately 200 e-posters sharing investigative results.
The Forum also features the Kenneth P. Johnson Memorial Lecture, which will be delivered by Dr. Benjamin M. Segal of The Ohio State University.
The 2021 Forum will again include the presentation of the National Multiple Sclerosis Society’s annual Barancik Prize. The prize recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality.
ACTRIMS is committed to fostering the careers of Young Investigators with an interest in MS. The first session of the Forum is composed of platform presentations by Young Investigators who were selected based on a review of the submitted abstracts. In addition, junior faculty, fellows and students who submit abstracts are eligible for an education grant to support their attendance. Neurologists in training will learn about career paths in clinical and investigative neuroimmunology through the pre-conference event, “Neurology Resident Summit in Multiple Sclerosis.”
Media can apply for complimentary registration for the 2021 Forum by completing the application form online. An Opening Press Conference will be held on Tuesday, February 23, 2021, at 3:00 p.m. CT to provide media with the opportunity to speak with Forum Program Committee Chair, Dr. Anne Cross and Vice Chair, Dr. Catherine Larochelle, along with ACTRIMS President Dr. Jeffrey Cohen.
To learn more about the Forum, visit the event website, https://forum.actrims.org/, and follow the event at #ACTRIMS on Twitter.
# # #
About ACTRIMS Founded in 1995, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) is a community of leaders from the United States and Canada who are dedicated to the treatment and research in MS and other demyelinating diseases. ACTRIMS focuses on knowledge dissemination, education, and collaboration among disciplines.
